Answers are grounded in this paper and cite their sources.
Post-hoc analysis assesses factors influencing outcomes of SGLT2 inhibitors in diabetic macular oedema, indicating important variations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ishibashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: